SCHEMBL8832009

SCHEMBL8832009

Brc1ccc2c3nc4ccccc4[nH]c-3nc2c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 1/20 0.68
ALDH1A1 P00352 5/20 0.53
SMN1; SMN2 Q16637 5/20 0.53
NPC1 O15118 4/20 0.53
RAB9A P51151 4/20 0.53
KDM4E B2RXH2 3/20 0.53
HSD17B10 Q99714 3/20 0.53
PKM P14618 2/20 0.53
NPSR1 Q6W5P4 2/20 0.53
TP53 P04637 2/20 0.53
ABCB11 O95342 1/20 0.53
FGFR1 P11362 2/20 0.51
FLT1 P17948 1/20 0.51
ESR1 P03372 1/20 0.50
MAPT P10636 3/20 0.49
MEN1 O00255 1/20 0.49
HTT P42858 1/20 0.49
KMT2A Q03164 1/20 0.49
GAA P10253 1/20 0.47
CHEK1 O14757 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30277951 0.82 NPC1 (0.67) PDPK1ALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL717809 0.82 NPC1 (0.67) PDPK1ALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL3537735 0.81 PDPK1 (1.00) PDPK1FGFR1FLT1CHEK1CDK2
SCHEMBL9725328 0.76 PDPK1 (0.61) PDPK1ALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL5951751 0.75 PDPK1 (0.80) PDPK1FGFR1FLT1CHEK1CDK2
SCHEMBL28114190 0.75 PDPK1 (0.60) PDPK1ALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL3741834 0.74 PTGES (0.55) PDPK1ALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL31429607 0.74 AMY1A (0.62) PDPK1ALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL481735 0.74 NPC1 (0.72) ALDH1A1SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL1284008 0.73 KDM4E (0.67) PDPK1ALDH1A1SMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5597921-A ANTITUMOR AGENTS, TREATMENT OF LEUKEMIA TAISHO PHARMACEUTICAL CO., LTD. (JP) 1997-01-28 US disclosed
EP-0695754-A1 INDOLO 2,3-b]QUINOXALINE DERIVATIVE TAISHO PHARMACEUTICAL CO. LTD (JP) 1996-02-07 EP disclosed